[Clinical results of a peroral combination therapy in infantile tuberculosis].
D000447:Aldehydes / Q000627:therapeutic use*; D002648:Child; D003131:Combined Modality Therapy; D006801:Humans; D007223:Infant; D009525:Niacin / Q000031:analogs & derivatives; D009539:Nicotinic Acids; D013882:Thiosemicarbazones / Q000627:therapeutic use*; D014376:Tuberculosis; D014397:Tuberculosis, Pulmonary
D000447:Aldehydes; D009539:Nicotinic Acids; D013882:Thiosemicarbazones; D009525:Niacin
ALDEHYDES/therapeutic use; NICOTINIC ACID/derivatives; THIOSEMICARBAZONES/therapeutic use; TUBERCULOSIS, PULMONARY/in infant and child
Klinische Ergebnisse einer peroralen Kombinationstherapie kindlicher Tuberkulose.